1. Products
  2. Asenapine Sublingual Tablets

Asenapine Sublingual Tablets are indicated for 

  • Bipolar I disorder
    • Adjunctive treatment to lithium or valproate in adults
Asenapine Sublingual Tablets
  • Compare to
    Saphris®*
Inactive Ingredients

Copovidone, crospovidone, polyoxyl 35 castor oil, mannitol, magnesium stearate, citric acid, butylated hydroxytoluene, silicon dioxide, sodium bicarbonate and black cherry flavor. 

*Saphris® is a registered trademark of Allergan.

Asenapine Sublingual Tablets (5 mg)

  • Package size
    60 ct
  • Rating
    AB
  • Strength
    5 mg
  • NDC Code
    42794-0016-10
Asenapine Sublingual Tablets (5 mg)

Asenapine Sublingual Tablets (10 mg)

  • Package size
    60 ct
  • Rating
    AB
  • Strength
    10 mg
  • NDC Code
    42794-0017-10
Asenapine Sublingual Tablets (10 mg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.